ONO EI-601 structure
|
Common Name | ONO EI-601 | ||
---|---|---|---|---|
CAS Number | 155023-59-9 | Molecular Weight | 350.35 | |
Density | 1.533g/cm3 | Boiling Point | N/A | |
Molecular Formula | C15H14N2O6S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ONO EI-601ONO-EI-601 is the major metabolite of human neutrophil elastase inhibitor ONO-5046. ONO-5046 has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19[1]. |
Name | 2-[[2-[(4-hydroxyphenyl)sulfonylamino]benzoyl]amino]acetic acid |
---|---|
Synonym | More Synonyms |
Description | ONO-EI-601 is the major metabolite of human neutrophil elastase inhibitor ONO-5046. ONO-5046 has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19[1]. |
---|---|
Related Catalog | |
References |
Density | 1.533g/cm3 |
---|---|
Molecular Formula | C15H14N2O6S |
Molecular Weight | 350.35 |
Exact Mass | 350.05700 |
PSA | 144.67000 |
LogP | 2.73600 |
Index of Refraction | 1.664 |
Glycine,N-(2-(((4-hydroxyphenyl)sulfonyl)amino)benzoyl) |
Ono-EI-601 |
N-(2-(((4-Hydroxyphenyl)sulfonyl)amino)benzoyl)glycine |
N-(2-(4-Hydroxyphenylsulfonylamino)benzoyl)aminoacetate |
N-(2-(p-Hydroxyphenylsulfonylamino)benzoyl)glycine |